Program highlights
Could genetic testing unlock treatments for Cancer of Unknown Primary?
World CUP Week: Researchers are screening hundreds of tumour genes in search of drug targets that could open the door to more personalised cancer care
Program update – September 2021
Here is an update on latest developments in FT3 including ideas to get involved and engage your network.
2020 From Testing to Targeted Treatment Annual Report
Moving from incubation to a shared operational program
Warnyta lost her partner to Cancer of Unknown Primary. Heartbreak inspired her to spearhead a campaign for the ... reimbursement of whole genome sequencing so that others might be spared the same fate. Read her story at http://ow.ly/LHdH30rUvhC - @TumorOnbekend #MakeTheMysteryHistory
The challenges in making #precisionmedicine more accessible to patients are complex. @FT3Program is developing a ... canvas resource to understand the access barriers at every step of the patient pathway. Want to learn more & contribute? Join us at #PEOF. RSVP http://ow.ly/JX5k30rTcm3
On this CUP World Awareness Week. @CupAwareness will be hosting a series of webinars. CUP experts will discuss ... current treatment limitations, new research & the role of newer diagnostics and therapies including #precisionmedicine. Don't miss out! RSVP 👉 http://worldcupawareness.org
About us
Our motivation
All patients deserve access to the right testing & treatment at the right time. While Personalized and Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.
Our ambition
Our goal is to accelerate the benefits of PM by generating better evidence, creating awareness and building the conditions for better access to targeted medicine in oncology and beyond.
The partnership
We are an independent, nonprofit, global and multistakeholder consortium, building with patients for patients. Its members include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.
Keep up to date with developments from the precision medicine ecosystem
We don’t spam. Just key info at the right time.
Founding members
